Control and severity: Complementary approaches to asthma management

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 2, 2007, Pages 116-119

  Roche, N ^a   Godard, P ^b  

^a HÔTEL DIEU   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN E ANTIBODY; THEOPHYLLINE;

ASTHMA; DISEASE CONTROL; DISEASE SEVERITY; DRUG DOSE INCREASE; EDITORIAL; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING;

ASTHMA; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 33846123327     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01223.x     Document Type: Editorial

References (28)

1. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2002;19:61-67.
2. Sullivan SD, Rasouliyan L, Russo PA, Kamath T, Chipps B, for the TENOR Study Group. Extent, patterns and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy 2007;62:126-133.
3. Schatz M, Mosen D, Apter AJ, Zeiger RS, Vollmer WM, Stibolt TB et al. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 2005;115: 1049-1055.
4. van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben Joseph R et al. Persistent asthma: disease control, resource utilisation and direct costs. Eur Respir J 2002;20:260-267.
5. van Ganse E, Antonicelli L, Zhang Q, Laforest L, Yin DD, Nocea G et al. Asthma-related resource use and cost by GINA classification of severity in three European countries. Respir Med 2006;100:140-147.
6. National Heart Lung and Blood Institute, National Institute of Health. Global Initiative for Asthma; Global strategy for asthma management and prevention; NHLBI/WHO workshop report 02-3659, 2005:1-176.
7. Roche N, Morel H, Martel P, Godard P. Clinical practice guidelines: medical follow-up of patients with asthma - adults and adolescents. Respir Med 2005;99:793-815.
8. Yawn BP, van der Molen T, Humbert M. Asthma management: are GINA guidelines appropriate for daily clinical practice? Prim Care Respir J 2005;14:294-302.
9. Piecoro LT, Potoski M, Talbert JC, Doherty DE. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state medicaid population. Health Serv Res 2001;36:357- 371.
10. Braganza S, Sharif I, Ozuah PO. Documenting asthma severity: do we get it right? J Asthma 2003;40:661-665.
11. Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142-149.
12. Wolfenden LL, Diette GB, Krishnan JA, Skinner EA, Steinwachs DM, Wu AW. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 2003;163:231-236.
13. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006;100:648-657.
14. Saint-Pierre P, Bourdin A, Chanez P, Daures JP, Godard P. Are overweight asthmatics more difficult to control? Allergy 2006;61:79-84.
15. Godard P, Huas D, Sohier B, Pribil C, Boucot I. ER'Asthme, contrôle de l'asthme chez 16 580 patients suivis en médecine géné rale. Presse Med 2005;34:1351-1357.
16. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the genetics and environment of asthma. Eur Respir J 2000;15:470-477.
17. Katz PP, Yelin EH, Eisner MD, Blanc PD. Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 2002;89:251-258.
18. Chapman KR. Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature. Respir Med 2005;99:1350-1362.
19. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002;121:1824-1832.
20. Chouaid C, Vergnenegre A, Vandewalle V, Liebaert F, Khelifa A. The costs of asthma in France: an economic analysis by a Markov model. Rev Mal Respir 2004;21:493-499.
21. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836-844.
22. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Canadian Asthma Consensus Group. CMAJ 1999;161:S1-S61.
23. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJ, Pedersen SE et al. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006;61:531-536.
24. Ehrs PO, Nokela M, Stallberg B, Hjemdahl P, Wikstrom JE. Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 2006;129:925-932.
25. Szende A, Svensson K, Stahl E, Meszaros A, Berta GY. Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 2004;22:537-547.
26. Vollmer WM, Markson LE, O'Connor E, Sanocki LL, Fitterman L, Berger M et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999;160:1647-1652.
27. Bonala SB, Pina D, Silverman BA, Amara S, Bassett CW, Schneider AT. Asthma severity, psychiatric morbidity, and quality of life: correlation with inhaled corticosteroid dose. J Asthma 2003;40:691-699.
28. Peters D, Chen C, Markson LE, Allen-Ramey FC, Vollmer WM. Using an asthma control questionnaire and administrative data to predict healthcare utilization. Chest 2006;129:918-924.